Z. Z. Zheng and S. J. Robboy, Cervical squamous cell carcinoma. Robboy's Pathology of the Female Reproductive Tract, pp.227-247, 2009.

P. Boyle and J. Ferlay, Cancer incidence and mortality in Europe, Annals of Oncology, pp.481-488, 2004.

N. Li, S. Franceschi, R. Howell-jones, P. Snijders, and G. M. Clifford, Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication, Int J Cancer, vol.128, pp.927-935, 2011.

A. Raithatha, I. Papadopoulou, V. Stewart, T. D. Barwick, A. G. Rockall et al., Cervical Cancer Staging: A Resident's Primer: Women's Imaging. RadioGraphics, pp.933-934, 2016.

D. G. Mitchell, B. Snyder, F. Coakley, C. Reinhold, G. Thomas et al., Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study, J Clin Oncol, vol.24, pp.5687-5694, 2006.

S. Nougaret, M. Horta, E. Sala, Y. Lakhman, I. Thomassin-naggara et al., Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology, Eur Radiol, vol.29, pp.792-805, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02420660

F. Kokka, A. Bryant, E. Brockbank, M. Powell, and D. Oram, Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database of Systematic Reviews, 2015.

J. A. Green, J. M. Kirwan, J. F. Tierney, P. Symonds, L. Fresco et al., Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, vol.358, pp.781-786, 2001.

P. Morice, C. Uzan, Y. Zafrani, Y. Delpech, S. Gouy et al., The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer, Gynecol Oncol, vol.107, pp.122-126, 2007.

F. Flueckiger, F. Ebner, H. Poschauko, K. Tamussino, R. Einspieler et al., Cervical cancer: serial MR imaging before and after primary radiation therapy-a 2-year follow-up study. Radiology. 1992, pp.89-93

E. Vincens, C. Balleyguier, A. Rey, C. Uzan, E. Zareski et al., Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results, Cancer, vol.113, pp.2158-2165, 2008.

M. Exner, A. Kühn, P. Stumpp, M. Höckel, L. Horn et al., Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment, Acta Radiologica, pp.869-877, 2016.

G. Engin, Cervical cancer: MR imaging findings before, during, and after radiation therapy, pp.313-324, 2006.

J. Menczer, I. Usviatzov, E. Ben-shem, A. Golan, and T. Levy, Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?, J Gynecol Oncol, vol.22, pp.183-187, 2011.

K. Kinkel, M. Ariche, A. A. Tardivon, A. Spatz, D. Castaigne et al., Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging, Radiology, vol.204, pp.55-63, 1997.

A. Jalaguier-coudray, R. Villard-mahjoub, A. Delouche, B. Delarbre, E. Lambaudie et al., Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study, pp.432-442, 2017.

Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, S. Ikeda et al., Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy, Radiology, vol.216, pp.803-809, 2000.

D. Cibula, R. Pötter, F. Planchamp, E. Avall-lundqvist, D. Fischerova et al., The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer, Radiother Oncol, vol.127, pp.404-416, 2018.

L. Li, M. Wu, S. Ma, X. Tan, and S. Zhong, Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study, Int J Clin Oncol, 2019.

Z. Chen, Y. Shi, S. Wang, and Q. Lu, Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients, Oncotarget, vol.8, pp.59609-59617, 2017.

F. Kokka, A. Bryant, E. Brockbank, M. Powell, and D. Oram, Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database of Systematic Reviews, 2015.

W. Zhang, C. Chen, P. Liu, W. Li, M. Hao et al., Impact of pelvic MRI in routine clinical practice on staging of IB1-IIA2 cervical cancer, Cancer Manag Res, vol.11, pp.3603-3609, 2019.

S. Fiset, M. L. Welch, J. Weiss, M. Pintilie, J. L. Conway et al., Repeatability and reproducibility of MRI-based radiomic features in cervical cancer, Radiother Oncol, vol.135, pp.107-114, 2019.

T. Wang, T. Gao, J. Yang, X. Yan, Y. Wang et al., Preoperative prediction of pelvic lymph nodes metastasis in early-stage cervical cancer using radiomics nomogram developed based on T2-weighted MRI and diffusion-weighted imaging, Eur J Radiol, vol.114, pp.128-135, 2019.

P. Balcacer, A. Shergill, and B. Litkouhi, MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls, Abdom Radiol (NY), vol.44, pp.2557-2571, 2019.

M. Exner, A. Kühn, P. Stumpp, M. Höckel, L. Horn et al., Value of diffusionweighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment, Acta Radiologica, pp.869-877, 2016.

A. Jalaguier-coudray, R. Villard-mahjoub, A. Delouche, B. Delarbre, E. Lambaudie et al., Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study, Radiology, vol.284, pp.432-442, 2017.

H. Hawighorst, P. G. Knapstein, U. Schaeffer, M. V. Knopp, G. Brix et al., Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions, AJR Am J Roentgenol, vol.166, pp.401-408, 1996.

Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, S. Ikeda et al., Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy, Radiology, vol.216, pp.803-809, 2000.

K. Kinkel, M. Ariche, A. A. Tardivon, A. Spatz, D. Castaigne et al., Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging, Radiology, vol.204, pp.55-63, 1997.

V. Goh, A. R. Padhani, and S. Rasheed, Functional imaging of colorectal cancer angiogenesis, Lancet Oncol, vol.8, pp.245-255, 2007.

M. J. Gollub, I. Blazic, S. Felder, A. Knezevic, M. Gonen et al., Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer, European Radiology, pp.1104-1113, 2019.

C. E. Loo, H. J. Teertstra, S. Rodenhuis, M. J. Van-de-vijver, J. Hannemann et al., Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results, AJR Am J Roentgenol, vol.191, pp.1331-1338, 2008.

D. Mariagrazia, A. F. Gabriella, F. , F. F. , D. S. et al., Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications, Gynecol Oncol, vol.99, pp.166-70, 2005.

J. M. Classe, P. Rauch, J. F. Rodier, P. Morice, E. Stoeckle et al., Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer), Gynecol Oncol, vol.102, pp.523-529, 2006.

E. Azria, P. Morice, C. Haie-meder, A. Thoury, P. Pautier et al., Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma, Ann Surg Oncol, vol.12, pp.332-337, 2005.

D. Kushner and S. Uppal, Faculty of 1000 evaluation for Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. F1000 -Post-publication peer review of the biomedical literature, 2012.

G. Houvenaeghel, L. Lelievre, M. Buttarelli, J. Jacquemier, X. Carcopino et al., Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma, Eur J Surg Oncol, vol.33, pp.498-503, 2007.

F. Flueckiger, F. Ebner, H. Poschauko, K. Tamussino, R. Einspieler et al., Cervical cancer: serial MR imaging before and after primary radiation therapy--a 2-year follow-up study. Radiology. 1992, pp.89-93

A. R. Padhani, G. Liu, D. M. Koh, T. L. Chenevert, H. C. Thoeny et al., Diffusionweighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations, Neoplasia, vol.11, pp.102-125, 2009.

C. K. Kuhl, P. Mielcareck, S. Klaschik, C. Leutner, E. Wardelmann et al., Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?, Radiology, vol.211, pp.101-110, 1999.

I. Thomassin-naggara, I. Toussaint, N. Perrot, R. Rouzier, C. A. Cuenod et al., Characterization of complex adnexal masses: value of adding perfusion-and diffusionweighted MR imaging to conventional MR imaging, Radiology, vol.258, pp.793-803, 2011.

K. Hatano, Y. Sekiya, H. Araki, M. Sakai, T. Togawa et al., Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging, Int J Radiat Oncol Biol Phys, vol.45, pp.639-644, 1999.